Editorial Commentary: Trichomonas vaginalis Testing and Screening in a High-Risk Population: Is This a Glimpse Into the Future?

Taylor, Stephanie N.

doi:10.1093/cid/ciu448

Cited by 5 publications

(3 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…As discussed elsewhere [19][20][21][22], there are no established T. vaginalis screening, surveillance, or control programs for women or men in the United States. Because of this limited public health response, T. vaginalis is considered a "neglected STI" [21,23].…”

Section: (See the Major Article By Patel Et Al On Pages 211-7)mentioning

confidence: 99%

See 1 more Smart Citation

Why Does Trichomonas vaginalis Continue to be a “Neglected” Sexually Transmitted Infection?

Muzny

2018

Clinical Infectious Diseases

View full text Add to dashboard Cite

Section: (See the Major Article By Patel Et Al On Pages 211-7)mentioning

confidence: 99%

“…However, this has also not been systematically investigated. Finally, a perceived lack of public interest in T. vaginalis may reflect a lack of public knowledge [20]. Because of the lack of national screening ).…”

Section: (See the Major Article By Patel Et Al On Pages 211-7)mentioning

confidence: 99%

Why Does Trichomonas vaginalis Continue to be a “Neglected” Sexually Transmitted Infection?

Muzny

2018

Clinical Infectious Diseases

View full text Add to dashboard Cite

“…[ 21 ] Despite the higher prevalence and severity of TV infection, the public health response has been inadequate, [ 22 ] and TV infection has been regarded as a “neglected” STI. [ 23 ] In addition, the asymptomatic nature of the infection and nonavailability of baseline data in many Nigerian communities, particularly in Enugu State, necessitate the assessment of the TV prevalence among adults in the study region.…”

Section: Introductionmentioning

confidence: 99%

Prevalence of trichomoniasis infection among adults in Nigerian community settings

Obetta,

Ogbonna,

Oyigbo

et al. 2023

Medicine

View full text Add to dashboard Cite

Background: Trichomonas vaginalis (TV) is a sexually transmitted pathogen. The study was conducted to determine its prevalence among 300 adult patients in 4 public health facilities in the Nsukka District of Enugu State, Nigeria. Method: The researchers collected high vagina swabs and urine samples were collected from 150 men and 150 women, respectively. The specimens were scrutinized for color, odor of discharge and urine, and motile trichomoniasis. Results: The prevalence of the TV was 45.0% (135/300) with women showing the highest prevalence (63.7%). Among the patients attending the University of Nigeria, Nsukka Medical Center, the prevalence was the highest at 31.9%. TV infection was more common among older adults aged 38 to 47 years (39.3%), married adults (76.3%), and those with secondary education (68.9%). Urogenital analysis reported that males with pains during urination were 51.0% and males with penile tingling were 12.2%. The highest vaginal Hydrogen ion concentration level of 6.8 was observed in women aged 38 to 47 years. Additionally, the results reported that Vaginal candidiasis, Bacterial vaginosis, and Herpes simplex virus type 2 antibodies were not independently associated with TV infection. In the unadjusted analysis, the odds of TV infection were higher in men (8.1), while Chlamydia trachomatis infection was higher in women (8.8). Among the adults diagnosed with herpes simplex virus type 2 antibodies, the odds of TV infection were 3.9 for both men and women. Men with penile human papillomavirus infection had lower odds of TV infection (1.9), while women with vaginal human papillomavirus infection had higher odds of TV infection (2.2). Conclusion: The prevalence of TV infection is high among sexually active adults in the Nigerian community. It is therefore crucial to implement the increased public health actions such as regular and early diagnosis to reduce its prevalence.

show abstract

Amaurocine: Anti- Trichomonas vaginalis protein produced by the basidiomycete Amauroderma camerarium

Duarte

Seixas

Carvalho

et al. 2016

Experimental Parasitology

View full text Add to dashboard Cite

Trichomonas vaginalis is the causative agent of trichomoniasis, the most common nonviral STD worldwide. This infection can lead to severe health conditions, especially when women are affected. Metronidazole and tinidazole are the only choices of treatment. In this sense, natural bioactive compounds against T. vaginalis are an interesting approach in the search for more efficient therapies. Herein, amaurocine, a 12 kDa protein, produced by the mushroom Amauroderma camerarium was purified and tested against T. vaginalis, including two fresh clinical isolates. Amaurocine presented MIC values at 2.6 μM against the ATCC isolate 30236, and 5.2 μM against the fresh clinical isolates, TV-LACH1 and TV-LACM2. Furthermore, besides increasing human neutrophils nitric oxide release, amaurocine presented a low toxicity toward those cells, suggesting it exerts a proinflammatory character.

show abstract

Editorial Commentary: Trichomonas vaginalis Testing and Screening in a High-Risk Population: Is This a Glimpse Into the Future?

Cited by 5 publications

References 14 publications

Why Does Trichomonas vaginalis Continue to be a “Neglected” Sexually Transmitted Infection?

Why Does Trichomonas vaginalis Continue to be a “Neglected” Sexually Transmitted Infection?

Prevalence of trichomoniasis infection among adults in Nigerian community settings

Amaurocine: Anti- Trichomonas vaginalis protein produced by the basidiomycete Amauroderma camerarium

Contact Info

Product

Resources

About